Related Experiment Videos
Hydroxyurea is a carbonic anhydrase inhibitor.
Andrea Scozzafava1, Claudiu T Supuran
1Università degli Studi di Firenze, Dipartimento di Chimica, Laboratorio di Chimica Bioinorganica, Via della Lastruccia 3, Rm. 188, I-50019 Sesto Fiorentino, Firenze, Italy.
Bioorganic & Medicinal Chemistry
|April 26, 2003
Summary
Hydroxyurea weakly inhibits carbonic anhydrase (CA) isozymes I and II by binding directly to the metal center. This interaction informs the design of novel CA and matrix metalloproteinase (MMP) inhibitors.
Area of Science:
- Biochemistry
- Enzyme kinetics
- Structural biology
Background:
- Cytosolic carbonic anhydrases (hCA I and hCA II) are crucial enzymes.
- Understanding their inhibition mechanisms is vital for therapeutic development.
Purpose of the Study:
- To investigate the interaction of hydroxyurea with hCA I and hCA II.
- To elucidate the binding mode and inhibition mechanism of hydroxyurea.
- To explore the potential of hydroxyurea as a scaffold for designing new enzyme inhibitors.
Main Methods:
- Kinetic assays to determine inhibition constants.
- Spectroscopic techniques (UV-Vis) to study enzyme-inhibitor adducts.
- X-ray crystallography data interpretation for binding mode analysis.
Main Results:
- Hydroxyurea is a weak, non-competitive inhibitor of hCA I and hCA II (Ki ≈ 0.1 mM).
- Spectroscopic data indicate direct binding of hydroxyurea to the catalytic Zn(II) center.
- A hypothetical binding mode involves coordination via nitrogen and hydrogen bonding.
Conclusions:
- Hydroxyurea directly interacts with the active site metal ion of carbonic anhydrase.
- The binding mode suggests hydroxyurea can serve as a template for designing inhibitors.
- This study paves the way for developing potent inhibitors for both carbonic anhydrases and matrix metalloproteinases.